---
title: Navan
date: 2019-05-31T08:39:58Z
modified: 2026-08-11T11:19:27Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/navan/"
type: portfolio
status: publish
excerpt: ""
wpid: 71811
language:
  - English
post_translations:
  - pll_5cf0e83e1e142
branchen22:
  - R&D Tools
sectors:
  - Diagnostics & R&D Tools
focus_areas:
  - R&D Tools
timestamp: 2026-08-11T11:19:27Z
tags:
  - English
  - pll_5cf0e83e1e142
  - R&D Tools
  - Diagnostics & R&D Tools
---

## Beschreibungstext

NAVAN, Inc. (NAVAN) is an early-stage private biotechnology company developing a novel, proprietary NanoStraw platform to enable the next generation of cell and gene therapies. A non-viral physical delivery technology, NanoStraws provide direct access to the cytosol of a cell and enable the delivery of Any Cargo into Any Cell in a gentle, non-perturbative manner. High cell viability, the ability to have multiple deliveries of different cargos into a cell, and no cargo size limitations are hallmarks of the platform. Cell transformation via NanoStraws will drastically reduce the complexity, cost and technical challenges involved in cell therapy manufacturing, allowing NAVAN to actively pursue the development of innovative therapies in a broad range of indications with its strategic collaborators and partners.

## Unternehmenswebsite

www.navanbio.com

## Adresse

329 Oyster Point Blvd, 3rd Floor, South San Francisco, CA 94080

## Kontakt

Array